Cargando…
Impact of the gut microbiota on immune checkpoint inhibitor-associated toxicities
Immune checkpoint inhibitors (ICIs) have transformed the treatment of patients with advanced cancers. However, the majority of patients do not respond or develop early progressive disease. A substantial number also develop immune-mediated toxicities that may lead to early treatment discontinuation....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747860/ https://www.ncbi.nlm.nih.gov/pubmed/31555343 http://dx.doi.org/10.1177/1756284819870911 |